New Pricing System Could Deal A Blow To South Korea's Generic-Dependent Companies
This article was originally published in PharmAsia News
Executive Summary
SEOUL - As part of its effort to root out illegal rebates, the Ministry for Health, Welfare and Family Affairs said it would launch a new "drug-pricing system" in October aimed at compensating hospitals that buy drugs at lower prices than their government-set maximum prices